Levine Leichtman Capital Partners Acquires Signature Resolution
Headquartered in
With LLCP's investment, Signature plans to accelerate geographic expansion, invest in platform capabilities, and continue broadening equity participation among its neutral base. Signature will continue to be led by the four founders,
"We are thrilled to partner with Signature, a true industry leader with one of the strongest panels of mediators and arbitrators in the country," said
"We believe LLCP is the right partner to support our next phase of growth," said
Signature is the tenth platform investment in LLCP Lower Middle Market Fund III, L.P. Across its funds, LLCP has invested extensively in the legal services space, including investments in the Expert Institute, Law Business Research, Resolution Economics, BigHand, Best Lawyers and West Academic.
LLCP was advised by Honigman LLP. Signature was advised by Stubbs Alderton & Markiles LLP.
About Levine Leichtman Capital Partners
Levine Leichtman Capital Partners, LLC is a global middle-market private equity firm with a 41-year track record of investing across various targeted sectors, including Business Services, Franchising & Multi-unit, Education & Training and Engineered Products & Manufacturing. LLCP utilizes a differentiated Structured Private Equity investment strategy, combining debt and equity capital investments in portfolio companies. LLCP believes that by investing in a combination of debt and equity securities, it offers management teams growth capital in a highly tailored, flexible investment structure that can be a more attractive alternative than traditional private equity.
LLCP's global team of dedicated investment professionals is led by 9 partners who have worked at LLCP for an average of 20 years. Since inception, LLCP and its affiliates have managed approximately
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/levine-leichtman-capital-partners-acquires-signature-resolution-302654568.html
SOURCE Levine Leichtman Capital Partners, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
- QScreen AI Announces Adoption of Semi-Annual Reporting
- New Workshop Kits Let Any Organization Teach Seniors Without Hiring an Expert
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share